IDO1 and pancreatic adenocarcinoma: When correlating the expression of IDO, VISTA, LAG3, and TIM3 with survival, we unexpectedly found IDO-positive tumors associated with a significantly longer overall survival (OS) in patients with resected pancreatic adenocarcinomas.